Fig. 7From: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort studyHCRU following FF/UMEC/VI initiation. HCRU healthcare resource utilization, FF/UMEC/VI fluticasone furoate/umeclidinium/vilanterol, GP general practitioner, CI confidence interval, A&E Accident and Emergency, COPD chronic obstructive pulmonary diseaseBack to article page